Episode Details

Please support this podcast by checking out our sponsors:
- Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily
- Lindy is your ultimate AI assistant that proactively manages your inbox - https://try.lindy.ai/tad
- Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron


Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily

Today's topics:

RNA-triggered CRISPR cell kill - Researchers demonstrated Cas12a2, an RNA-guided CRISPR system that can trigger a targeted “kill switch” when a specific RNA transcript is present—potentially useful for cancer, antiviral work, and safer cell selection.

North Korea–Russia bridge near completion - Satellite analysis suggests a new road bridge over the Tumen River will soon link North Korea and Russia, reinforcing trade and possibly easing the movement of military supplies amid the Ukraine war.

Russia-linked assassination plots in Europe - Western officials say suspected Russian-backed plots to kill activists and Ukraine supporters across Europe have increased, using criminal proxies and creating intimidation even when attacks fail.

Europe shifts naval posture near Hormuz - France is moving the Charles de Gaulle carrier group toward the Red Sea as Europe weighs a defensive maritime mission tied to the Strait of Hormuz disruption, insurance costs, and global oil flows.

New drug progress in pancreatic cancer - Early data on daraxonrasib—aimed at the RAS pathway—suggests improved survival in advanced pancreatic cancer, raising hopes while also highlighting notable side effects and the need for confirmation.

Measles antibodies hint at post-exposure help - Scientists isolated potent measles-neutralizing antibodies from a vaccinated donor, pointing toward possible post-exposure protection for infants and immunocompromised people during U.S. outbreaks.

Mapping the human dark proteome - A growing body of work is cataloging microproteins from the so-called “dark proteome,” revealing overlooked biology tied to mitochondria, cell division, DNA repair, and potential tumor targets.

EU bans abusive deepfake AI - A provisional EU deal would ban AI tools built to generate child sexual abuse material or non-consensual intimate images, setting clearer enforcement baselines and forcing safety measures by December.

Episode Transcript

RNA-triggered CRISPR cell kill
In science and health, a new twist on CRISPR is getting a lot of attention. Researchers say the enzyme Cas12a2 can be programmed to wipe out eukaryotic cells only when a chosen RNA transcript is present. In plain terms: instead of just editing DNA, this system can act like a highly selective “on-switch” for cell death—triggering only in cells that are expressing the target message. The early demonstrations include selectively knocking down HPV-positive cancer cells and distinguishing a well-known KRAS mutation in lab tests. It’s still early, and delivery and safety remain big hurdles, but the significance is clear: this could become a new way to remove the “right” cells while sparing the rest.

North Korea–Russia bridge near completion
Another major biomedical headline: an experimental drug called daraxonrasib is raising expectations in